Role of Magnetic Resonance Imaging Within Diagnostic Criteria for Multiple Sclerosis
Ann Neurol 56:273-278, Miller,D.H.,et al, 2004
Clinical Implications of Benign Multiple Sclerosis: A 20-Year Population-Based Follow-Up Study
Ann Neurol 56:303-306, Pittock,S.J.,et al, 2004
West Nile Virus Infection in the United States
Arch Neurol 61:1190-1195, Tyler,K.L., 2004
Five New Cases of a Recently Described Leukoencephalopathy with High Brain Lactate
Neurol 63:688-692, Linnankivi,T.,et al, 2004
Clinicopath Conf, Multiple-System Atrophy
NEJM 351:912-921, Case 27-2004, 2004
Migraine Is Associated With Magnetic Resonance Imaging White Matter Abnormalities
Arch Neurol 61:1366-1368, Swartz,R.H.,et al, 2004
Neurologic Impairment 10 Years After Optic Neuritis
Arch Neurol 61:1386-1389, Optic Neuritis Study Group, 2004
The Natural History of Recurrent Optic Neuritis
Arch Neurol 61:1401-1405, Pirko,I.,et al, 2004
European Study on Intravenous Immunoglobulin in Multiple Sclerosis
Arch Neurol 61:1409-1412, Filippi,M.,et al, 2004
The Prevalence of Pain in Multiple Sclerosis, A Multicenter Cross-Sectional Study
Neurol 63:919-921, Solaro,C.,et al, 2004
Hemorrhagic Infarction in White Matter Following Acute Carbon Monoxide Poisoning
Neurol 63:1102-1105, Finelli,P.F. & DiMario,J.F., 2004
Interferon Beta-1a for Brain Tissue Loss in Patients at Presentation with Syndromes Suggestive of Multiple Sclerosis: A Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 364:1489-1496,1463, Filippi,M.,et al, 2004
Relapsing-Remitting Multiple Sclerosis and Human Herpesvirus 6 Active Infection
Arch Neurol 61:1523-1527, Alvarez-Lafuente,R.,et al, 2004
Long-Term Brain Magnetic Resonance Imaging Changes After Optic Neuritis in Patients Without Clinically Definite Multiple Sclerosis
Arch Neurol 61:1538-1541, Optic Neuritis Study Group, 2004
Intravenous Immunoglobulin Treatment Following the First Demyelinating Event Suggestive of Multiple Sclerosis
Archn Neurol 61:1515-1520, Achiron,A.,et al, 2004
Treatment-Induced Leukoencephalopathy in Primary CNS Lymphoma,A Clinical and Autopsy Study
Neurol 62:451-456, Lai,R.,et al, 2004
Reversible Leukoencephalopathy Associated with Cerebral Amyloid Angiopathy
Neurol 62:494-497, Oh,U.,et al, 2004
Migraine as a Risk Factor for Subclinical Brain Lesions
JAMA 291:427-434, Kruit,M.C.,et al, 2004
Diffusion-Weighted Imaging Findings in Juvenile Metachromatic Leukodystrophy
Neuropediatrics 35:279-282, Oguz,K.K.,et al, 2004
Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL)
Pract Neurology 4:50-55, Razvi,S.S.M. &Muir,K.W., 2004
CADASIL: Cerebral Autosomal Subcortical Infarcts and Leukoecephalopathy
, Chabriat, H., Joutel A., Vahedi, K., Tournier-Lasserve, &E., Bousser M.G., 2004
A Case of Reversible Postpartum Cytotoxic Edema in Preeclampsia
JNeuroSci 221:83-87, Na,S.-J.,et al, 2004
Cerebral Infarction in Eclampsia
Am J Obstet Gyncol 190:714-720, Zeeman,G.G.,et al, 2004
Reversible Corpus Callosum Lesion in Legionnaires Disease
JNNP 75:651-654, Morgan, J.C.,et al, 2004
MR Imaging Presentation of Intracranial Disease Associated with Langerhans Cell Histiocytosis
AJNR 25:880-891, Prayer, D.,et al, 2004
Clinical Manifestations of Cerebral Amyloid Angiopathy-Related Inflammation
Ann Neurol 55:250-256, Eng,J.A.,et al, 2004
Atypical manifestations of reversible posterior leukoencephalopathy syndrome: findings on diffusion imaging and ADC mapping
Nueroradiology 46:978-983, Ahn, K.J.,et al, 2004
Conventional and Diffusion-Weighted MRI in the Evaluation of Methanol Poisoning
Acta Radiologica 44:691-695, Server, A.,et al, 2003
Silent Infarcts Demonstrated by Diffusion-Weighted MRI in CADASIL
Eur Neurol 49: 178-180, Moon,S.Y.,et al, 2003
Diffusion-Weighted MR Findings in Isolated Angilitis of the Central Nervous System (IACNS)
Acta Neurol Scand 108:346-351, Lee, S.-Y.,et al, 2003
Tonic Pupil and Sarcoidosis
AJO 135:417-419, Bowie,E.M.&Givre,S.J., 2003
Severe Tacrolimus Leukoencephalopathy After Liver Transplantation
AJNR 24:2085-2088, Schuuring,J.,et al, 2003
Acute Marchiafava-Bignami Disease: MR Findigns in Two Patients
AJNR 24:1955-1957, Arbelaez,A.,et al, 2003
MR Features of Diseases Involving Bilateral Middle Cerebellar Peduncles
AJNR 24:1946-1954, Okamoto,K.,et al, 2003
Symmetric Deep Cerebellar Lesions After Smoking Heroin
Arch Neurol 60:1605-1606, Ropper,A.H. &Blair,R., 2003
MRI Findings in Susac's Syndrome
Neurol 61:1783-1787, Susac,J.O.,et al, 2003
Leukoencephalopathy with Vanishing White Matter: An Adult Onset Case
Neurol 61:1818-1819, Biancheri,R.,et al, 2003
The CNS Phenotype of X-Linked Charcot-Marie-Tooth Disease
Neurol 61:1475-1478, Taylor,R.A.,et al, 2003
Prevalence and Clinical Features of HTLV Neurologic Disease in the HTLV Outcomes Study
Neurol 61:1588-1594, Orland,J.R.,et al, 2003
Three Subsequent Single Doses of Gadolinum Chelate for Brain MR Imaging in Multiple Sclerosis
AJNR 24:658-662, Sardanelli,F.,et al, 2003
Clinical Relevance of Atrial Fibrillation/Flutter, Stroke, Pacemaker Implant, and Heart Failure in Emery-Dreifuss Muscular Dystrophy
Stroke 34:901-908, Boriani,G.,et al, 2003
Clinicopath Conf., Colchicine Myoneuropathy
NEJM 349:1656-1663, Case 33-2003, 2003
Benign Calf Amyotrophy
Arch Neurol 60:1415-1420, Felice,K.J.,et al, 2003
Smoking is a Risk Factor for Multiple Sclerosis
Neurol 61:1122-1124, Riise,T.,et al, 2003
Primary Progressive Aphasia--A Language-Based Dementia
NEJM 349:1535-1542, Mesulam,M.-M., 2003
Clinical Importance of Neutralising Antibodies Against Interferon Beta in Patients with Relapsing-Remitting Multiple Sclerosis
Lancet 362:1184-1191, Sorensen,P.S.,et al, 2003
Neuropathological Findings in West Nile Virus Encephalitis: A Case Report
Ann Neurol 54:547-551, Agamanolis,D.P.,et al, 2003
Subcortical White Matter Infarcts, Comparison of Superficial Perforating Artery and Internal Border-Zone Infarcts Using Diffusion-Weighted Magnetc Resonance Imaging
Stroke 34:2630-2635, Lee,P.H.,et al, 2003
Genetic, Clinical, and Radiographic Delineation of Hallervorden-Spatz Syndrome
NEJM 348:33-40, Hayflick,S.J.,et al, 2003
A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
NEJM 348:14-23, Miller,D.H.,et al, 2003